arrow_back Trending Legislation
Share share

September Designated as National Ovarian Cancer Awareness Month

This House Resolution supports designating September as National Ovarian Cancer Awareness Month. The goal is to raise public awareness about the disease, its symptoms, and risk factors, which can lead to earlier detection and better treatment outcomes for women.
Key points
Ovarian cancer is a serious disease often found late due to the lack of an easy early detection test and vague symptoms.
Increasing awareness of symptoms and risk factors (like family history or BRCA genes) is crucial for earlier diagnosis.
The resolution highlights the need for better access to care and genetic testing, especially for populations facing health disparities.
article Official text account_balance Process page notifications_active Track this Bill
gavel
Status:
Expired
Record your position for audit.
Why does your vote on bills matter?
It creates raw, undeniable proof. Civic Will provides the permanent data to verify the Government's loyalty towards its citizens (explained here). Start recording it now.
Additional Information
Supporting the designation of September 2021 as "National Ovarian Cancer Awareness Month".
Print number: HRES 687
Sponsor: Rep. DeLauro, Rosa L. [D-CT-3]
Process start date: 2021-09-28
System Note: Lustra is free, publicly auditable civic infrastructure, with full source code available on GitHub. You are reading sterilized legislative data, processed by our radical neutrality engine to strip political spin and retain factual mechanics. We process only official government data. Original documents remain the authoritative source, always verify them if you can.
Summarized by: gemini-2.5-flash-preview-04-17
Source data: api.congress.gov
AI work logs for this document launch
Summary & Status

Key Questions about September Designated as National Ovarian Cancer Awareness Month

A structured overview of the legislative process, official sources, status and civic context.

What is the official ID of this bill?

The official print number for this legislation is HRES 687.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2021-09-28.

What are the main provisions?

Key points include:

  • Ovarian cancer is a serious disease often found late due to the lack of an easy early detection test and vague symptoms.
  • Increasing awareness of symptoms and risk factors (like family history or BRCA genes) is crucial for earlier diagnosis.
  • The resolution highlights the need for better access to care and genetic testing, especially for populations facing health disparities.

What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. DeLauro, Rosa L. [D-CT-3].

What is the latest detailed status?

The latest detailed status is: Referred to the House Committee on Oversight and Reform.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-27.

Analysis and Potential Impact of HRES 687

We don't know, that is up to you to decide. Summarizing raw data with AI is fundamentally different from predicting socio-economic outcomes. As of 2026, we believe impact assessment strictly requires a human in the loop to verify and judge. Review our public AI processing logs for full transparency, and use Lustra to track active legislation for instant status push notifications.

CATEGORIES

Health